Der aktuelle Stand der Sequenzierungsverfahren wird hier von weltweit führenden Experten diskutiert.
About the Author: The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.
176 Pages
Medical, Pharmacology
Series Name: Novartis Foundation Symposia
Description
Book Synopsis
Der aktuelle Stand der Sequenzierungsverfahren wird hier von weltweit führenden Experten diskutiert. Daneben wird ein Ausblick auf neue Entwicklungen geboten, wobei der Schwerpunkt auf der Anwendung genetischer Informationen in der Wirkstofforschung liegt. Rechtliche und ethische Aspekte der Verwendung dieser Informationen werden ebenfalls angesprochen. (03/00)
From the Back Cover
Recent technological advances have led to a rapid acceleration in our ability to gather genetic data. The complete genetic sequences are now known to several organisms and accelerated programmes are in place for sequencing many other genomes, including human. The speed with which complete sequencing can be accomplished will continue to increase as new technologies come online. In principle, the scope for developing new diagnostic techniques and drugs is now greater than at any time in human history, but the pathway from genetic information to usable drug is a long and complex one.
This exciting book brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. The subjects covered include the current state of the art in sequencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomes from the point of view of the pharmaceutical industry.
Review Quotes
"It does successfully convey to the reader areas of controversy" (Microbiology Today, November 2001) "there are a number of nuggets in the book that make it worth a browse." (Pharmaceutical Physician, December 2001) "I found this book fun to read." (Biochemistry & Molecular Biology Education, No.29 2001) "Contributors...present 17 papers and the discussions they generated at the symposium." (SciTech Book News, Vol. 25, No. 4, December 2001)
About the Author
The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.
Dimensions (Overall): 9.0 Inches (H) x 6.0 Inches (W) x .56 Inches (D)
Weight: .95 Pounds
Suggested Age: 22 Years and Up
Number of Pages: 176
Genre: Medical
Sub-Genre: Pharmacology
Series Title: Novartis Foundation Symposia
Publisher: Wiley
Format: Hardcover
Author: Gregory R Bock & Dalia Cohen & Jamie A Goode
Language: English
Street Date: November 8, 2000
TCIN: 1008775647
UPC: 9780471627449
Item Number (DPCI): 247-05-7351
Origin: Made in the USA or Imported
If the item details aren’t accurate or complete, we want to know about it.
Shipping details
Estimated ship dimensions: 0.56 inches length x 6 inches width x 9 inches height
Estimated ship weight: 0.95 pounds
We regret that this item cannot be shipped to PO Boxes.
This item cannot be shipped to the following locations: American Samoa (see also separate entry under AS), Guam (see also separate entry under GU), Northern Mariana Islands, Puerto Rico (see also separate entry under PR), United States Minor Outlying Islands, Virgin Islands, U.S., APO/FPO
Return details
This item can be returned to any Target store or Target.com.
This item must be returned within 90 days of the date it was purchased in store, shipped, delivered by a Shipt shopper, or made ready for pickup.